Investing in Ultragenyx Pharmaceutical Inc.? If so, we recommend checking out these offers as well (we believe these to be much more interesting):
Cannabis Trader: https://logistics-business-review.com/cannabis-trader-for-RARE-investors
Trade Netflix: https://logistics-business-review.com/netflix-for-RARE-investors
Wall Street Journal: https://logistics-business-review.com/wsj-for-RARE-investors (only $12 for 12 weeks – everyone should get this)
REPORTING FOR 2019-07-29 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how Ultragenyx Pharmaceutical Inc. ($RARE) has been trading over the last 2 weeks and the past day especially. On its latest session, Ultragenyx Pharmaceutical Inc. ($RARE) opened at 60.25, reaching a high of 62.42 and a low of 60.02 before closing at a price of 62.25. There was a total volume of 327708.
VOLUME INDICATORS: We saw an accumulation-distribution index of 320.41827, an on-balance volume of 60.13, chaikin money flow of 1.21198 and a force index of 0.948. There was an ease of movement rating of 0.00578, a volume-price trend of -2.20096 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 1.66983, bolinger bands of 60.03914, an upper bollinger band of 60.01086, lower bollinger band of 60.02, a bollinger high band indicator of 1.0, bollinger low band indicator of nan, a central keltner channel of 60.89667, high band keltner channel of 58.72667, low band keltner channel of 63.06667, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 60.02, a donchian channel low band of 60.02, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.00022, a MACD signal of 0.00012, a MACD difference of 0.0001, a fast Exponential Moving Average (EMA) indicator of 60.02, a slow Exponential Moving Average (EMA) indicator of 60.02, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.99788, a trix of -1.55658, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 2.22829, a KST Oscillator (KST) of -35.79679 and a KST Oscillator (KST Signal) of -35.79679 (leaving a KST difference of 0.04016). We also found an Ichimoku rating of 61.335, an Ichimoku B rating of 61.335, a Ichimoku visual trend A of 63.91135, an Ichimoku visual trend B of 62.64895, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 49.16939, a True Strength Index (TSI) of -100.0, an ultimate oscillator of 50.0, a stochastic oscillator of 110.59908, a stochastic oscillator signal of 110.59908, a Williams %R rating of 10.59908 and an awesome oscillator of 0.18925.
RETURNS: There was a daily return of -3.57968, a daily log return of 0.01666 and a cumulative return of 0.01666.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-29 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Ultragenyx Pharmaceutical Inc. ($RARE)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Ultragenyx Pharmaceutical Inc., we strongly advise Ultragenyx Pharmaceutical Inc. investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like Ultragenyx Pharmaceutical Inc. – without this you are trading blind:
We will of course continue to cover the news and price action of Ultragenyx Pharmaceutical Inc., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Ultragenyx Pharmaceutical Inc. ($RARE) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.
Latest posts by Gary Ivenchuck (see all)
- What ZTO Express (Cayman) Inc. ($ZTO) Traders Should Know (2019-08-23) - August 23, 2019
- Zoetis Inc. ($ZTS) Recap From An Expert (2019-08-23) - August 23, 2019
- A Deep Analysis of Zimmer Biomet Holdings, Inc. ($ZBH) (2019-08-23) - August 23, 2019